相关实验视频
Updated: Jun 14, 2026
09:37
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
Published on: October 26, 2009
37.0K
药物通过3D电膨胀结合聚合物水凝输送
Ilaria Abdel Aziz1,2, Johannes Gladisch1, Sophie Griggs3
1Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, 601 74 Norrköping, Sweden. eleni.stavrinidou@liu.se.
Journal of materials chemistry. B
|April 8, 2024
概括
这项研究介绍了一种用于电控药物递送的新型合聚合物水凝,能够加载和释放像胰岛素这样的大分子. 该材料允许有模式的释放和多重重载,从而推进治疗应用.
科学领域:
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
- 聚合物化学 聚合物化学
背景情况:
- 电控药物输送系统对于最小化副作用和实现精确的治疗剂量至关重要.
- 现有的合聚合物 (CP) 系统由于合并限制,仅限于提供小分子 (高达500Da).
- 较大的分子通常需要共聚合,限制药物输送到单个释放事件.
研究的目的:
- 开发一种结合聚合物系统,能够使用显著的体积变化来控制更大的分子 (800-6000 Da) 的输送.
- 通过使用一种新型的糖化多二烯 (p(g3T2) 来研究各种分子重量的加载和释放机制.
- 为先进的药物输送应用展示暂时模式释放和多重重装循环.
主要方法:
- 使用了糖化聚二烯 (p(g3T2)) 水凝,在电化学兴奋剂后显示高达300%的可逆体积变化.
- 开发了p(g3T2) 涂层的3D碳海绵,用于控制分子的加载和释放.
- 通过静电相互作用和物理捕获来研究负荷,以及包括胰岛素在内的多达6000Da的分子的释放动态.
主要成果:
- 成功地证明了控制的载荷和释放的分子范围从800-6000Da,包括激素胰岛素.
- 展示了一个1300 Da分子的暂时模式释放.
- 实现了多个重新加载和释放周期,而不会影响系统的开/关开关比.
结论:
- 合聚合物水凝 p(g3T2) 能够控制多种分子大小的输送,克服了以前的限制.
- 该系统有助于精确的时间控制药物释放,并允许重复加载和卸载周期.
- 这项技术对先进的时空药物递送系统和治疗应用具有重大潜力.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...